Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...

The American College of Physicians (ACP) has developed new recommendations for treatment of acute episodic migraines in nonpregnant adults in outpatient settings.

DEA and HHS have delayed implementation of two rules for telehealth prescribing of buprenorphine until the end of the year to ...

Suboxone is a prescription medication that treats ... methadone is also approved by the Food and Drug Administration (FDA) ...

We are excited to present four posters with important real-world data from our differentiated pain portfolio at PainConnect 2025 and are grateful to AAPM for selecting our poster at its meeting as a ...

While buprenorphine is the first-line treatment ... You feel uncomfortable, you feel pain, you want to use," he said. "So, the body signals that link to all the natural emotions, as well as ...

Increasing prevalence of cancer Drives Buprenorphine Market Growth from USD 5.52 Bn in 2023 • In terms of Application, the Opioid segment is expected to exhibit the highest share during the forecast ...

Buprenorphine (as HCl) 2mg, 8mg; sublingual tabs. Dissolve under tongue; do not swallow tabs. Avoid food or drinks until tab dissolves. Rinse teeth/gums with water after tab dissolves, and swallow ...

Sublocade is a buprenorphine-containing long-acting injectable ... discomfort where the needle went in, such as pain or itching; and higher liver enzyme levels. The FDA warns against using the ...

Although nearly midnight, the team members, known as “Night Navigators,” connected him via telephone to the San Francisco Department of Public Health’s (SFDPH) telehealth buprenorphine ...